Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

505.64
+3.330.66%
Post-market: 505.800.1600+0.03%19:30 EDT
Volume:806.78K
Turnover:408.89M
Market Cap:128.29B
PE:29.43
High:511.51
Open:504.08
Low:503.94
Close:502.31
52wk High:560.25
52wk Low:400.86
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.81
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.34
PE(LYR):33.01

Loading ...

May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 13, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Major Issues Report

Form 8-K - Current report
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 02, 2026

Correspondence

Form CORRESP - Correspondence
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities